# Indaptus Therapeutics, Inc.: Form 8-K, filed Jul 1, 2025

- Company: [Indaptus Therapeutics, Inc.](/companies/indp.md) (CIK 1857044)
- Form: 8-K
- Filed: 2025-07-01
- Accepted by EDGAR: Jul 1, 2025, 12:38 ET
- Period: 2025-06-30
- Accession: 0001641172-25-017283
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1857044/000164117225017283/form8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1857044/000164117225017283/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation
- Item 3.02: Unregistered sale of equity
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1857044/000164117225017283/form8k.htm

Filed Jul 1, 2025.
Source: SEC EDGAR, the filing index for accession 0001641172-25-017283. Last ingested by Listed: Oct 24, 2026, 15:16 ET. No prices; not investment advice.